Table 1.
Compare between ELMO1-AS1 expression and clinicopathological characteristics in HCC patients
Training set | Validation set | Combined set | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Clinicopathologic Parameters | Total (n=110) | Low (n=55) | High (n=55) | P-value | Total (n=112) | Low (n=56) | High (n=56) | P-value | Total (n=222) | Low (n=111) | High (n=111) | P-value |
Gender | 0.801 | 0.341 | 0.239 | |||||||||
Female | 19 | 9 | 10 | 11 | 4 | 7 | 30 | 12 | 18 | |||
Male | 91 | 46 | 45 | 101 | 52 | 49 | 192 | 99 | 93 | |||
Age (years) | 0.057 | 0.280 | 1.000 | |||||||||
<55 | 88 | 40 | 48 | 96 | 50 | 46 | 184 | 92 | 92 | |||
≥55 | 22 | 15 | 7 | 16 | 6 | 10 | 38 | 19 | 19 | |||
Tumor number | 0.606 | 0.645 | 0.304 | |||||||||
<3 | 92 | 47 | 45 | 88 | 43 | 45 | 180 | 93 | 87 | |||
≥3 | 18 | 8 | 10 | 24 | 13 | 11 | 42 | 18 | 21 | |||
Tumor diameter | 0.189 | 0.357 | 0.113 | |||||||||
<5 cm | 28 | 11 | 17 | 24 | 10 | 14 | 52 | 21 | 31 | |||
≥5 cm | 82 | 44 | 38 | 88 | 46 | 42 | 170 | 90 | 80 | |||
AFP | 1.000 | 0.057 | 0.178 | |||||||||
<400 ng/ml | 58 | 29 | 29 | 50 | 20 | 30 | 108 | 49 | 59 | |||
≥400 ng/ml | 52 | 26 | 26 | 62 | 36 | 26 | 114 | 62 | 52 | |||
PVTT | 0.039 | 1.000 | 0.178 | |||||||||
No | 97 | 45 | 52 | 94 | 47 | 47 | 191 | 92 | 99 | |||
Yes | 13 | 10 | 3 | 18 | 9 | 9 | 31 | 19 | 12 | |||
Microsatellite | 0.185 | 0.324 | 0.239 | |||||||||
No | 100 | 48 | 52 | 92 | 44 | 48 | 192 | 93 | 99 | |||
Yes | 10 | 7 | 3 | 20 | 12 | 8 | 30 | 18 | 12 | |||
MVI | 0.340 | 0.038 | 0.060 | |||||||||
No | 55 | 25 | 30 | 55 | 22 | 33 | 110 | 48 | 62 | |||
Yes | 55 | 30 | 25 | 57 | 34 | 23 | 112 | 63 | 49 | |||
TNM stage | 0.152 | 0.287 | 0.139 | |||||||||
I+II | 75 | 34 | 41 | 72 | 34 | 38 | 147 | 69 | 78 | |||
III+IV | 35 | 21 | 14 | 38 | 22 | 16 | 73 | 42 | 31 |
Abbreviations: AFP, alpha-fetoprotein; PVTT, portal vein tumor thrombus; MVI, microvascular invasion.